References
- Karstila K, Korpela M, Sihvonen S, Mustonen J. Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study. Clin Rheumatol 2007;26:2089–95.
- Koseki Y, Terai C, Moriguchi M, Uesato M, Kamatani N. A prospective study of renal disease in patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:327–31.
- Daoussis D, Panoulas VF, Antonopoulos I, John H, Toms TE, Wong P, . Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:517–21.
- Karie S, Gandjbakhch F, Janus N, Launay-Vacher V, Rozenberg S, Mai Ba CU, . Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology 2008;47:350–4.
- Braun A, Zeier M. Rheumatoid arthritis and the kidney: uneasy companions. Nephron Clin Pract 2005;96:c105–6.
- Sihvonen S, Korpela M, Mustonen J, Laippala P, Pasternack A. Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 2004;96:c107–14.
- Pixley J, Wolf B, O’Neill W. Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab. Scand J Rheumatol 2008;37:313–14.
- Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, . Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049–60.
- Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Clin Chem 2009;55:1932–43.
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41.
- Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461–70.
- Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 2007;22:1087–92.
- Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 2006;21:1855–62.
- Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, . Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006;145:237–46.
- Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007;115:173–9.
- Emberson JR, Haynes R, Dasgupta T, Mafham M, Landray MJ, Baigent C, . Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men. J Intern Med 2010;268:145–54.
- Sato H, Kuroda T, Tanabe N, Ajiro J, Wada Y, Murakami S, . Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis. Scand J Rheumatol 2010;39:33–7.
- Karstila K, Harmoinen AP, Lehtimaki TJ, Korpela MM, Mustonen JT, Saha HH. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance. Nephron Clin Pract 2008;108:c284–90.
- Hayashi T, Ito S, Goto D, Matsumoto I, Sumida T. Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis. Mod Rheumatol 2010;20:548–55.
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–324.
- Prevoo ML, ‘t Hof van MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that includes twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
- Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases. J Rheumatol 2005; 32:1432–9.
- Hoek FJ, Kemperman FAW, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003;18:2024–31.
- Fliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens 2008;17:604–8.
- Knight EL, Verhave JC, Spiegelman D, Hillege HL, Zeeuw DD, Curhan GC, . Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416–21.
- Harmoinen A, Lehtimaki T, Korpela M, Turjanmaa V, Saha H. Diagnostic accuracies of plasma creatinine, cystatin C, and glomerular filtration rate calculated by the Cockcroft-Gault and Levey (MDRD) formulas. Clin Chem 2003;49:1223–5.
- Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njolstad I, . Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 2010; 78:1305–11.
- Odden MC, Tager IB, Gansevoort RT, Bakker SJ, Katz R, Fried LF, . Age and cystatin C in healthy adults: a collaborative study. Nephrol Dial Transplant 2010;25:463–9.
- Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, . Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009;75:652–60.
- Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, . Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 2007; 71:239–44.
- Keller C, Katz R, Sarnak MJ, Fried LF, Kestenbaum B, Cushman M, . Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. Nephrol Dial Transplant 2010;25:119–24.
- Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, . Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003;107:87–92.
- Goeb V, Jouen F, Gilbert D, Le Loet X, Tron F, Vittecoq O. Diagnostic and prognostic usefulness of antibodies to citrullinated peptides. Joint Bone Spine 2009;76:343–9.
- Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001;47:2055–9.